Latest posts

How the Legality of a Popular Hemp-Based Compound Weighs on Cannabis Stocks


When Congress passed the 2018 Farm Bill and the U.S. president signed it in December of that year, hemp was removed from the list of Schedule I drugs that includes heroin, cocaine and marijuana. Products derived from industrial hemp containing less than 0.3% by weight of delta-9 tetrahydrocannabinol (THC) became legal and led to what became known as Cannabis 2.0, the sale of non-psychoactive products derived from industrial hemp.

Hemp industry struggles with federal regulations

Hemp — and the CBD products that can be made from it — may have been legalized by the 2018 federal farm bill, but members of the nascent industry say new federal rules make it almost impossible to make hemp products without breaking the law.

An alphabet soup of federal and state agencies oversees the growth, processing and distribution of hemp and its byproducts.

Is Trump Willing To Lose the Election for Marijuana Prohibition?

Recently, the excellent website, MarijuanaMoment.com, carried two articles by Kyle Jaeger, their Los Angeles-based associate editor, "Trump Voices Concern That Putting Marijuana On The Ballot Makes Republicans Lose" and "Biden's Marijuana Decriminalization Plan Is 'Meaningless', says Democratic Congressman"; that really makes me wonder i

Five Months Into The Pandemic, How Is The Cannabis Industry Doing?

In early 2020, the world as we know it changed when COVID-19 erupted into a global health crisis. This virus continues to wreak havoc on public safety and the economy, sparing no community or industry. Despite these challenges, the cannabis industry has shown incredible resilience through these uncertain times. 

Insurers missing an opportunity in burgeoning cannabis market

In 2018, sales of medical and recreational cannabis in the United States were nearly nine times higher than sales of Oreo cookies, according to a report from New Dawn Risk entitled, ‘Understanding and opening up the US cannabis insurance market’. Despite the significant demand – the US market saw an estimated $8 billion in legalized cannabis sales in 2018 – there are a few big problems blocking the way to further progress in the US cannabis industry.

Cannabis Markets Outside of North America to Keep an Eye On

Canada and the U.S. currently generate a majority of the cannabis industry’s revenue. While both countries are significant factors as the market matures, other nations will take up a share as well.

For example, Mexico, New Zealand and several other countries are considering adult use legalization, and could assume their place in the global market.

Several cannabis industry experts told Benzinga that several regions and nations are already ones to keep an eye on when tracking the global marijuana growth.

Marijuana use is on the rise in older adults

Marijuana use is on the rise among baby boomers in the United States, especially men, according to a study published Monday in the Annals of Internal Medicine.

The findings appear to reflect changing attitudes toward cannabis across the country, study co-author Bill Jesdale, an assistant professor of population and quantitative health science at the University of Massachusetts Medical School in Worchester, suggested.

US House of Reps will vote on marijuana legalization next month

The House will vote on legalizing marijuana next month.

States would still have to vote to legalize the drug. Marijuana is already legal in 11 states.

The MORE Act would remove cannabis from the Controlled Substances Act and erase some cannabis criminal records. The vote will come during the September work period, according to an email Majority Whip Jim Clyburn’s (D-S.C.) office that was sent to members Friday.

US Spent $1.49B On Cannabis Research from 2000-2018

The United States spent $1.49 billion on cannabis research between 2000 and 2018. Most of the funds were directed at understanding the potential harms of cannabis use.

The United States spent $1.49 billion on cannabis funding from 2000-2018, according to a Science report. The majority of the funds were spent on understanding potential harms from cannabis use.

Top Marijuana Stock To Expand In Canada's Biggest Retail Market

Canopy Growth (CGC) on Friday said it would open 10 physical retail locations next week in Alberta, the first of its stores to appear in a province that already has far more pot shops than any other. Canopy Growth stock and other marijuana stocks rose.

The company, which is the biggest marijuana stock by market cap, said it would open both its Tweed and Tokyo Smoke shops in the province, with most appearing in Calgary. Canopy said it was hiring 100 people in Alberta connection with the openings.